⚠ COVID-19 INFORMATION: Resources, Vaccine Information


Filter by:


Trisomy 21 and COVID-19 in Pediatric Patients

Newman, A. M.; Jhaveri, R.; Patel, A. B.; Tan, T. Q.; Toia, J. M.; Arshad, M. J Pediatr. 2020 Aug 31

Anaerobic Antibiotics and the Risk of Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Tanaka, J. S.; Young, R. R.; Heston, S. M.; Jenkins, K.; Spees, L. P.; Sung, A. D.; Corbet, K.; Thompson, J. C.; Bohannon, L.; Martin, P. L.; Stokhuyzen, A.; Vinesett, R.; Ward, D. V.; Bhattarai, S. K.; Bucci, V.; Arshad, M.; Seed, P. C.; Kelly, M. S. Biol Blood Marrow Transplant. 2020 Jul 20

The Gut of Healthy Infants in the Community as a Reservoir of ESBL and Carbapenemase-Producing Bacteria

Saleem, A. F.; Allana, A.; Hale, L.; Diaz, A.; Salinas, R.; Salinas, C.; Qureshi, S. M.; Hotwani, A.; Rahman, N.; Khan, A.; Zaidi, A. K.; Seed, P. C.; Arshad, M. Antibiotics (Basel). 2020 May 31; 9(6)

The pandemic Escherichia coli sequence type 131 strain is acquired even in the absence of antibiotic exposure

Whitmer, G. R.; Moorthy, G.; Arshad, M. PLoS Pathog. 2019 Dec 20; 15(12):e1008162